Corrigendum to "Overexpression of nucleotide metabolic enzyme DUT in hepatocellular carcinoma potentiates a therapeutic opportunity through targeting its dUTPase activity" [Cancer Lett., 548, (1 November 2022)]
Cancer Lett. 2024 Feb 28:583:216601.
doi: 10.1016/j.canlet.2023.216601.
Epub 2023 Dec 30.
1 Department of Surgery, Sir Y.K. Pao Centre for Cancer, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China.
2 Department of Surgery, Sir Y.K. Pao Centre for Cancer, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Shatin, Hong Kong, China. Electronic address: [email protected].